数据链接：
官方服务：
资源简介：
(XLSX)
应用场景：
创建时间：
2021-12-22
相关数据集
Supplementary Material for: ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic Targets
Summary of what is New or Different 1. This chapter recommends a target HbA1c of ≤6.5% (48mmol/mol) for those who have access to advanced diabetes technologies like continuous glucose monitoring (CGM
DataCite Commons2024-12-20 更新140
Using machine learning methods to predict the risk of exercise-induced hypoglycemia in people with Type 1 diabetes
Exercise offers a number of benefits to individuals with type 1 diabetes (T1D) (1), including reduced risk of coronary artery disease and stroke, as well as improved blood pressure (2,3), lowered dail
Mendeley Data2024-01-31 更新100
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective
Aims: To evaluate the cost-effectiveness of real-time continuous glucose monitoring (CGM) compared to self-monitoring of blood glucose (SMBG) alone in people with type 1 diabetes (T1DM) using m
DataCite Commons2020-09-01 更新50
Evaluation of diabetic patients after three month use of continuous subcutaneous insulin infusion, dispensed by a protocolled form at outpatient reference clinic of Taguatinga Regional Hospital
Objective To evaluate the data of continuous subcutaneous insulin infusion protocol (CSII) for diabetics waived by the Health State Secretariat of Distrito Federal (HSSDF) and therapeutic responses th
DataCite Commons2021-03-23 更新110
Characteristics of participants according to pay-for-performance category.
Figures are frequencies (percent) except where indicated. atest for difference between category and practices or patients not in that category. bfigures are median (IQR) for distribution of practice-s
NIAID Data Ecosystem70
